Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ming-teh D. Chen, MD
Women's Cancer Center - Los Gatos
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Community Hospital of Los Gatos
Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Women'S Cancer Center
Palo Alto, California, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Holden Comprehensive Cancer Center at the University of Iowa
Iowa City, Iowa, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 1998
- Primary completion
- 30 Apr 2006
- Completion
- —
- Last update posted
- 10 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00003382
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.